Navigation Links
Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin
Date:11/6/2007

SUNNYVALE, Calif., Nov. 6 /PRNewswire/ -- Pathwork Diagnostics, a genomics-based diagnostics company focused on oncology, announced today that Virginia Commonwealth University School of Medicine has initiated an investigational study of the Pathwork(TM) Tissue of Origin Test. The new genomics-based test is designed to help determine a tumor's origin so that tissue-specific management can begin. VCU's study makes it one of the first institutions in the country to evaluate this leading technology in patients who may have few remaining diagnostic options. The Tissue of Origin Test is also the focus of two workshops and two poster presentations at the 12th Annual Meeting of the Association for Molecular Pathology this week (November 7-10, Los Angeles).

"Patient cases in which a tumor cannot be readily identified are a significant problem," said Catherine Dumur, Ph.D., Director of Molecular Morphology Genomics for the Department of Pathology, VCU. "Such cases are time-consuming for physicians and anxiety-producing for patients, and are a challenge to providing the most appropriate care for the patient. We are eager to see how this investigational new genomics-based test extends and complements traditional histopathological approaches."

There are an estimated 200,000 cancer patients each year in the United States who may benefit from additional diagnostic information to determine the tissue of origin for their cancer. National Comprehensive Cancer Network guidelines emphasize the importance of identifying the tissue of origin so that management specific to the primary cancer can begin.

"We envision that in the future genomics data will become a useful ancillary tool to pathologists to answer complex cancer questions in a clinical setting," said Carleton Garrett, M.D. Ph.D., Director of the Tissue and Data Acquisition and Analysis Core at VCU. "Virginia Commonwealth University will continue to evaluate the use of such innovative technologies in ord
'/>"/>

SOURCE Pathwork Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. University of Leicester scientists discover technique to help friendly bacteria
7. MichBio Announces Student Career Day at Michigan State University
8. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
9. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
10. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
11. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...rstCall/ -- BioSpecifics Technologies Corp. (Nasda... first-in-class collagenase-based products, today ...ter ended September 30, 2009. ,, "We were extr...DA,s Arthritis Advisory Committee unanimously reco...X(TM) for the treatment of Dupuytren,s disease, an...
(Date:11/6/2009)...-FirstCall/ -- ,, 3Q09 Corporate Highlights:...arketing Authorization to Astellas Pharma Europe L...iness activities Expanded management team to incl...ctor, Commercial Operations Appointed Bradford S....chairman , Upcoming 2009 Milestones: ,...
(Date:11/6/2009)...rowhead’s 2010 Personalized Medicine Partner...bruary 22-24, 2010 in Philadelphia, has been annou...ht key issues in forming partnerships and engage t... Minneapolis, MN (PRWEB) Nove...2010 Personalized Medicine Partnerships Conference...
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...ced today,that the company initiated its pivotal P...tucel-L) in the treatment of advanced non-small ce... in the study was treated by,Dr. Lyudmila Bazhenov...sity,of California, San Diego School of Medicine.,...80821/LATH009-a ), (Photo: http://www.newscom.co...
...nderlying Cause of Cystic,Fibrosis; Oral Drug May ...ELD, N.J., Aug. 20 New phase 2 data,published tod...l drug,PTC124 demonstrates activity in nonsense-mu...eatment with PTC124 results in statistically signi...on of patients with,nonsense-mutation CF. The stud...
...ystems,(MMS) today announced a new partnership wit... the result of a legislative initiative that,estab...h benefit for North,Dakota state employees and oth...nce Pharmaceutical Care System(TM) will provide No...aining and technology to guide and,document the de...
Other Biology Technology:NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 2NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 3NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 4PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 2PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 3PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 4PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 5North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes 2
(Date:11/4/2009)...t,s the cost of saving a teenage life? When it com...rescription medication abuse, there,s no price tag...aware that the lock-boxes they,ve installed are no... of prescription drugs. That,s why MEDNET(TM), a n..., has formed an exclusive partnership with Axius H...
(Date:11/4/2009)...l/ -- BIO-key International, Inc. (OTC Bulletin Bo...ntification software is showcasing donor and patie...being held at the New Orleans Convention Center fr...on product demonstrations of its state-of-the-art ...5 PM on Monday, October 26, Peter Lux, manager of ...
(Date:11/4/2009)...sity of North Carolina at Chapel Hill School of Me...isco have developed and experimentally tested a te...g drugs. , The researchers developed a computati...es of all known drugs are to the naturally occurri...ase targets within the cell. In a study published ...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3BIO-key(R) International Exhibiting at AABB TXPO 2Study points to new uses, unexpected side effects of already existing drugs 2New Nominee for WHO Regional Director for Europe 57339 1New Nominee for WHO Regional Director for Europe 57339 2Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 1Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 2Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 3Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 4Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 1Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 2Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 3Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 4
...erta has helped map out the animal,s life span and...species lived, says new research conducted in part...rises to me was that the overall pattern of surviv...than the catastrophic model we were expecting," sa...e and professor in the U of A,s Department of Biol...
...eceptors in breast cancer may play a role in resis...xifen treatment, according to a study in the May 1...Pak 1 is a member of a family of proteins involved...cell movement, and cell death. Previous studies h...y lead to more invasive breast cancer. , Goran ...
...nsible for singing and mating are shrinking when e...of Alberta research--the first proof that natural ...ild animal. , "These residues have been persisti...turbing," said Dr. Andrew Iwaniuk, a post-doctoral...chology. "It has been years since it has been used...
Other Biology News:Tyrannosaur survivorship -- tough times for teens 2Pak1 expression increases tamoxifen resistance in breast cancer patients 2Bird brains shrink from exposure to contaminants 2
Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion
...are designed to rapidly and reliably amplify unkno... APAgene provides hassle-free, ready-to use compon... necessary ingredients are provided in each kit. T...t-end amplification of large clones such as P1, YA...
Rabbit Anti-Yaf9 Polyclonal Antibody, Unconjugated from Abcam
...is designed to deparaffinize and perform Heat Indu...affin-embedded tissue sections mounted on glass mi...by melting the paraffin at the high temperature us...ation of the paraffin by detergent. Formaldehyde f...
Biology Products: